Related Content

Trials of H1N1 Vaccines Begin in Children



Patterns of Diagnosed ADHD and LD, 1997–2006

Attention-deficit/hyperactivity disorder (ADHD) and learning disability (LD) are two of the most prevalent disorders occurring in children aged 6 to 17 years.

Eating Disorders

An eating disorder is an abnormal eating behavior that leads to serious physical and emotional problems.

Heparin-Induced thrombocytopenia: An Update

ABSTRACT: Heparin-induced thrombocytopenia (HIT) is a transient, prothrombotic state.

Trends in NDA Approvals

The research and development (R D) process for a new drug takes an average of 10 to 15 years and involves many discrete steps and activities.

MEDICATION MANAGEMENT

What's News 6/19/2008

Alexandria, VA -- A survey conducted by the American Society of Health-System Pharmacists (ASHP) uncovered that the number of health system pharmacists playing a significant role in consulting with physicians on a wide range of drug protocols increased by 2% over the past six years.

My Campaign Platform 4/18/2008

As the Presidential campaigns heat up, there has been much talk about fixing the U.

Cardinal Health Helps Hospitals Efficiently Order, Store, and Dispense Drugs 2/20/2008

Cardinal Health is partnering with hospitals nationwide to help them simplify the way that they purchase and dispense medications.

InforMedix Launches Med-eMonitor 1/28/2008

The Med-eMonitor System, a new interactive smart pillbox, was developed by InforMedix to address the problem of noncompliance among patients with chronic conditions and the elderly.

The Dawn of a New Age 1/23/2008

According to the U.S. Census Bureau, the average life expectancy for Americans is 78 years.

Review of Select NMEs 10/18/2007

New molecular entities (NMEs), as defined by the FDA, are new drug products that have as their active ingredient a chemical substance marketed for the first time in the United States.

New Drug Review 10/18/2007

New molecular entities (NMEs), as defined by the FDA, are new drug products that have as their active ingredient a chemical substance marketed for the first time in the United States.

New Therapies for HIV Infection 10/18/2007

Approximately 39.5 million people worldwide are infected with human immunodeficiency virus (HIV).

Pharmacy Technicians Are Valued Resources 5/18/2007

Let's face it: There isn't a pharmacist in practice that wants to make an error.

Drug Interactions in Dermatology 4/17/2007

M.

Review of Select NMEs 3/21/2007

New molecular entities (NMEs), as defined by the FDA, are new drug products that have as their active ingredient a chemical substance marketed for the first time in the United States.

Advertisement